NITYR

Serial Number 87604011
Registration 5716643
705

Registration Progress

Application Filed
Sep 11, 2017
Under Examination
Oct 30, 2018
Approved for Publication
Sep 4, 2018
Published for Opposition
Sep 4, 2018
Registered
Apr 2, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-02) (Grace Period Filing)
Due: Oct 02, 2025 Grace Period - 80 days
Original deadline was Apr 02, 2025 (overdue)

Trademark Image

NITYR

Basic Information

Serial Number
87604011
Registration Number
5716643
Filing Date
September 11, 2017
Registration Date
April 2, 2019
Published for Opposition
September 4, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
705
Status Date
May 21, 2025
Registration
Registered
Classes
005 035 044

Rights Holder

Cycle Pharmaceuticals Ltd.

03
Address
21 JJ Thomson Ave
The Broers Building
Cambridge CB3 0FA
GB

Ownership History

Cycle Pharmaceuticals Ltd.

Original Applicant
03
Cambridge GB

Cycle Pharmaceuticals Ltd.

Owner at Publication
03
Cambridge GB

Cycle Pharmaceuticals Ltd.

Original Registrant
03
Cambridge GB

Legal Representation

Attorney
Jaclyn Diffley

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-02)
Due Date
April 02, 2025
Grace Period Ends
October 02, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description
May 21, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 21, 2025 C15P O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 15, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 16, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 23, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED
Apr 3, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 3, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 3, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 28, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 27, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 26, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 26, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 15, 2019 GNRT O NON-FINAL ACTION E-MAILED
Feb 15, 2019 CNRT W SU - NON-FINAL ACTION - WRITTEN
Feb 14, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Feb 14, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 23, 2019 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 23, 2019 IUAF S USE AMENDMENT FILED
Jan 17, 2019 NOAC E CORRECTED NOA E-MAILED
Oct 30, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 4, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 4, 2018 PUBO A PUBLISHED FOR OPPOSITION
Aug 15, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 10, 2018 DOCK D ASSIGNED TO EXAMINER
Aug 1, 2018 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Jul 27, 2018 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 24, 2018 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Jul 13, 2018 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 12, 2018 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Jun 29, 2018 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 27, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED
Jun 27, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 27, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED
Jun 27, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jun 20, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2018 GNRT O NON-FINAL ACTION E-MAILED
May 1, 2018 CNRT R NON-FINAL ACTION WRITTEN

Detailed Classifications

Class 005
(Based on 44(e)) Pharmaceutical agents for the treatment of [ disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of ] tyrosinemia [ and hypertyrosinemia, all ] in the form of [ liquids, solutions, suspensions, syrups, drops, capsules, ] tablets [ , caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches ]
First Use Anywhere: Aug 1, 2017
First Use in Commerce: Aug 1, 2017
Class 035
[ (Based on 44(e)) Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches ]
Class 044
[ (Based on 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medical, pharmacological and pharmaceutical testing services in relation to rare diseases; medical, pharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases ]

Classification

International Classes
005 035 044

USPTO Documents

Loading USPTO documents...